Lee's Pharmaceutical Holdings Ltd. announced to its shareholders and potential investors that the results of the Group for the six months ended 30 June 2012 is expected to record an increase by over 50% as compared to the profit for the corresponding period in 2011. Based on the information currently available, the Board considers that such improvement is mainly attributable to sales of the Group's pharmaceutical products continued to maintain its growth momentum during the first six months of the year and the continual improvement in operating efficiency in its sales and marketing organization.